Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026)
Oculis Holding AG's (OCS) quarterly Beginning Cash Balance came in at $103.9 million in Q1 2026, up 237.0% year-on-year from $30.8 million in Q1 2025, and up 237.0% quarter-over-quarter from $30.8 million in Q1 2025.
Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026) Analysis & Trends
Oculis Holding AG's Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $103.9 million for Q1 2026.
- On a quarterly basis, Beginning Cash Balance rose 237.0% year-over-year to $103.9 million in Q1 2026; TTM through Mar 2026 was $103.9 million, a 237.0% increase from a year earlier, with the FY2025 full-year figure at $33.4 million, down 23.29% from the prior year.
- Beginning Cash Balance advanced to $103.9 million in Q1 2026 per OCS's latest filing, from $30.8 million in the prior quarter.
- Across five years, Beginning Cash Balance topped out at $103.9 million in Q1 2026 and bottomed at $21.4 million in Q1 2023.
- The 4-year median for Beginning Cash Balance is $37.4 million (2024), against an average of $50.0 million.
- Across the five-year window, Beginning Cash Balance declined 29.82% in 2025 and jumped 237.0% in 2026, its largest moves.
- Year by year, Beginning Cash Balance stood at $21.4 million in 2023, then soared by 105.27% to $43.9 million in 2024, then declined by 29.82% to $30.8 million in 2025, then jumped by 237.0% to $103.9 million in 2026.
- Per Business Quant, the three latest OCS Beginning Cash Balance figures stand at $103.9 million (Q1 2026), $30.8 million (Q1 2025), and $43.9 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.86 Mn |
| Mar 31, 2026 | 103.86 Mn |
| Mar 31, 2025 | 30.82 Mn |
| Mar 31, 2025 | 30.82 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Mar 31, 2023 | 21.39 Mn |
| Mar 31, 2023 | 21.39 Mn |